Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma

Background/Aims: Chronic hepatitis B (CHB) is a risk factor for non-Hodgkin lymphoma (NHL). Our recent study suggested that antiviral treatment may reduce the incidence of NHL in CHB patients. This study compared the prognoses of hepatitis B virus (HBV)-associated diffuse large B-cell lymphoma (DLBC...

Full description

Bibliographic Details

Published in:	Clinical and molecular hepatology Vol. 29; no. 3; pp. 794 - 809
Main Authors:	Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-hwan Yoon, Tae Min Kim, Jeong-hoon Lee
Format:	Journal Article
Language:	Korean
Published:	대한간학회 01-07-2023
Subjects:	Antiviral agent Chemotherapy Hepatitis B virus Non-Hodgkin lymphoma Rituximab
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!